Suchergebnisse - "DeJesus, Edwin"

PubPharm (275)

1

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment : a phase 1b, randomised, proof-of-concept study

enthalten in: The lancet. HIV | 2024

von Eron, J. | Little, S. | Crofoot, G. | +14

2

Racial/ethnic disparities in HIV care outcomes among insured patients at a large urban sexual health clinic

enthalten in: Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2023

von Mathai, R. | Hinestrosa, F. | DeJesus, E. | +1

3

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

enthalten in: The New England journal of medicine | 2023

von Grinspoon, S. | Fitch, K. | Zanni, M. | +124

CommentIn: Nat Rev Cardiol. 2023 Oct;20(10):648. - PMID 37587223

4

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV : week 52 results of a phase 2/3 trial

enthalten in: The lancet. HIV | 2023

von Ogbuagu, O. | Segal-Maurer, S. | Ratanasuwan, W. | +55

CommentIn: Lancet HIV. 2023 Aug;10(8):e486-e487. - PMID 37451298

5

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1 : five-year follow-up from two randomized trials

enthalten in: EClinicalMedicine | 2023

von Sax, P. | Arribas, J. | Orkin, C. | +13

6

Treatment-related early discontinuations and adverse events among newly diagnosed people living with HIV initiating integrase inhibitors in a real-world setting

enthalten in: Antiviral therapy | 2023

von Rolle, C. | Castano, J. | Nguyen, V. | +3

7

Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1 : a phase 1 clinical trial

enthalten in: Nature medicine | 2022

von Julg, B. | Stephenson, K. | Wagh, K. | +34

8

Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Gartland, M. | Cahn, P. | DeJesus, E. | +16

9

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

enthalten in: The New England journal of medicine | 2022

von Segal-Maurer, S. | DeJesus, E. | Stellbrink, H. | +57

CommentIn: N Engl J Med. 2022 May 12;386(19):1848-1849. - PMID 35544391

10

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study

enthalten in: Open forum infectious diseases | 2022

von Sutton, K. | De Vente, J. | Leblanc, R. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]